跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CSL New Zealand Alburex 20 NZ, Solution for infusion 20% - TGA Drug Approval Details
Approvals
/
TGA
/
CSL New Zealand Alburex 20 NZ, Solution for infusion 20%
Approved
STANDARD
CSL New Zealand Alburex 20 NZ, Solution for infusion 20%
CSL Behring (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
329120b878c679a3
Company
CSL Behring (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
329120b878c679a3
Product Name
CSL New Zealand Alburex 20 NZ, Solution for infusion 20%
Artg Id
430330
Artg Name
CSL New Zealand Alburex 20 NZ, Solution for infusion 20%
Sponsor
CSL Behring (Australia) Pty Ltd
Company Detail Path
/organization/csl-behring-australia-pty-ltd
Artg Date
2023-12-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
329120b878c679a3
Type
Standard
Back to TGA Approvals
